Moleculin Biotech (MBRX) Earnings Date, Estimates & Call Transcripts → The best inflation-proof investment (From DTI) (Ad) Free MBRX Stock Alerts $5.39 +0.35 (+6.94%) (As of 12:54 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueMBRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MBRX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Birch GoldThe Sneaky IRS Tax Law that's Sweeping the U.S.In the years immediately following 2008-09, as the economy stagnated, gold exploded in value. Today, Goldman Sachs is telling its clients that gold may reach $2,250 within the next few years. Don't miss your chance to diversify your savings.Request your info kit on gold now Moleculin Biotech Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($3.59)($3.59)($3.59)Q2 20241($2.82)($2.82)($2.82)Q3 20241($2.41)($2.41)($2.41)Q4 20241($2.53)($2.53)($2.53)FY 20244($11.35)($11.35)($11.35) Get Moleculin Biotech Earnings AlertsEnter your email address below to receive the latest news and earnings results for MBRX and its competitors with MarketBeat's FREE daily newsletter. MBRX Earnings Date and InformationMoleculin Biotech has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off prior year's report dates.Read More Moleculin Biotech Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/9/2024Estimated)------- 11/13/2023Q3 2023($3.15)($2.85)+$0.30($0.19)--8/11/2023Q2 2023($4.20)($3.00)+$1.20($0.20)--5/11/2023Q1 2023($3.75)($4.20)($0.45)($0.28)--3/22/2023Q4 2022($4.20)($3.60)+$0.60($0.24)--11/10/2022Q3 2022($4.05)($4.50)($0.45)($0.30)--8/15/2022Q2 2022($3.75)($3.60)+$0.15($0.24)-- Get the Latest News and Ratings for MBRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Moleculin Biotech and its competitors with MarketBeat's FREE daily newsletter. 5/11/2022Q1 2022($3.15)($3.60)($0.45)($0.24)--3/25/2022Q4 2021($3.15)($2.55)+$0.60($0.25)--11/11/2021Q3($3.00)($2.25)+$0.75($0.15)--8/10/2021Q2($2.8050)($2.25)+$0.5550($0.23)--5/11/2021Q1 2021($3.45)($3.00)+$0.45($0.20)-- Moleculin Biotech Earnings - Frequently Asked Questions When is Moleculin Biotech's earnings date? Moleculin Biotech has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off last year's report dates. Learn more on MBRX's earnings history. How much profit does Moleculin Biotech generate each year? Moleculin Biotech (NASDAQ:MBRX) has a recorded net income of -$29.77 million. MBRX has generated -$13.64 earnings per share over the last four quarters. What is Moleculin Biotech's EPS forecast for next year? Moleculin Biotech's earnings are expected to grow from ($10.93) per share to ($8.35) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Monopar Therapeutics Earnings Results Molecular Templates Earnings Results AgeX Therapeutics Earnings Results Aeterna Zentaris Earnings Results Elevai Labs Earnings Results Galera Therapeutics Earnings Results Guardion Health Sciences Earnings Results Imunon Earnings Results Eterna Therapeutics Earnings Results MIRA Pharmaceuticals Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:MBRX) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersDave Ramsey Shocks Millions With US Dollar LunacyAmerican Hartford Gold GroupTrump is sounding the alarmPreserve GoldBiden’s Sneaky H.R. 5376 Is A Nightmare For Retirement SaversBirch GoldThe best inflation-proof investment DTIAI “wealth window” is closing June 25thParadigm PressWatch this FREE trading tutorial while it’s still availableInvestorPlaceCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moleculin Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
